Home LiteratureArticle Details
PMID: 19244329 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

NF-kappaB serves as a cellular sensor of Kaposi's sarcoma-associated herpesvirus latency and negatively regulates K-Rta by antagonizing the RBP-Jkappa coactivator.

Journal of virology ·Vol. 83 ·No. 9 ·2009-05-00 ·Pages 4435-46

Izumiya Y, Izumiya C, Hsia D, Ellison TJ, Luciw PA, Kung HJ

Abstract

Successful viral replication is dependent on a conducive cellular environment; thus, viruses must be sensitive to the state of their host cells. We examined the idea that an interplay between viral and cellular regulatory factors determines the switch from Kaposi's sarcoma-associated herpesvirus (KSHV) latency to lytic replication. The immediate-early gene product K-Rta is the first viral protein expressed and an essential factor in reactivation; accordingly, this viral protein is in a key position to serve as a viral sensor of cellular physiology. Our approach aimed to define a host transcription factor, i.e., host sensor, which modulates K-Rta activity on viral promoters. To this end, we developed a panel of reporter plasmids containing all 83 putative viral promoters for a comprehensive survey of the response to both K-Rta and cellular transcription factors. Interestingly, members of the NF-kappaB family were shown to be strong negative regulators of K-Rta transactivation for all but two viral promoters (Ori-RNA and K12). Recruitment of K-Rta to the ORF57 and K-bZIP promoters, but not the K12 promoter, was significantly impaired when NF-kappaB expression was induced. Many K-Rta-responsive promoters modulated by NF-kappaB contain the sequence of the RBP-Jkappa binding site, a major coactivator which anchors K-Rta to target promoters via consensus motifs which overlap with that of NF-kappaB. Gel shift assays demonstrated that NF-kappaB inhibits the binding of RBP-Jkappa and forms a complex with RBP-Jkappa. Our results support a model in which a balance between K-Rta/RBP-Jkappa and NF-kappaB activities determines KSHV reactivation. An important feature of this model is that the interplay between RBP-Jkappa and NF-kappaB on viral promoters controls viral gene expression mediated by K-Rta.

MeSH Terms
Cell Line Down-Regulation Gene Expression Regulation, Viral Herpesvirus 8, Human/genetics,metabolism Humans Immediate-Early Proteins/genetics,metabolism Immunoglobulin J Recombination Signal Sequence-Binding Protein/antagonists & inhibitors,metabolism NF-kappa B/genetics,metabolism Promoter Regions, Genetic/genetics Trans-Activators/genetics,metabolism Virus Activation Virus Latency
Chemicals
Immediate-Early Proteins Immunoglobulin J Recombination Signal Sequence-Binding Protein NF-kappa B Rta protein, Human herpesvirus 8 Trans-Activators
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Izumiya Yoshihiro
Department of Dermatology,University of California, Davis School of Medicine, UC Davis Cancer Center, Sacramento, California 95817, USA. yizumiya@ucdavis.edu
Izumiya Chie
Hsia Datsun
Ellison Thomas J
Luciw Paul A
Kung Hsing-Jien
References (64)
64 references, click to expand
  1. Transcripts encoding K12, v-FLIP, v-cyclin, and the microRNA cluster of Kaposi's sarcoma-associated herpesvirus originate from a common promoter.
    J Virol. 2005 Nov;79(22):14457-64 PMID: 16254382
  2. Functional characterization of the M-type K15-encoded membrane protein of Kaposi's sarcoma-associated herpesvirus.
    J Gen Virol. 2007 Jun;88(Pt 6):1698-1707 PMID: 17485529
  3. The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs.
    Science. 2005 Feb 4;307(5710):739-41 PMID: 15692053
  4. NF-kappaB2 is a putative target gene of activated Notch-1 via RBP-Jkappa.
    Mol Cell Biol. 1998 Apr;18(4):2077-88 PMID: 9528780
  5. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
    J Virol. 2004 Jun;78(12):6585-94 PMID: 15163750
  6. CREB-binding protein and histone deacetylase regulate the transcriptional activity of Kaposi's sarcoma-associated herpesvirus open reading frame 50.
    J Virol. 2001 Feb;75(4):1909-17 PMID: 11160690
  7. Human Notch-1 inhibits NF-kappa B activity in the nucleus through a direct interaction involving a novel domain.
    J Immunol. 2001 Jul 1;167(1):289-95 PMID: 11418662
  8. Role of Notch signal transduction in Kaposi's sarcoma-associated herpesvirus gene expression.
    J Virol. 2005 Nov;79(22):14371-82 PMID: 16254371
  9. Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2.
    Mol Cell Biol. 1996 Mar;16(3):952-9 PMID: 8622698
  10. Crystal structure of the CSL-Notch-Mastermind ternary complex bound to DNA.
    Cell. 2006 Mar 10;124(5):985-96 PMID: 16530045
  11. Open reading frame 50 protein of Kaposi's sarcoma-associated herpesvirus directly activates the viral PAN and K12 genes by binding to related response elements.
    J Virol. 2002 Apr;76(7):3168-78 PMID: 11884541
  12. A histone deacetylase corepressor complex regulates the Notch signal transduction pathway.
    Genes Dev. 1998 Aug 1;12(15):2269-77 PMID: 9694793
  13. Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells.
    J Virol. 1999 Nov;73(11):9348-61 PMID: 10516043
  14. Activation of Src kinase Lyn by the Kaposi sarcoma-associated herpesvirus K1 protein: implications for lymphomagenesis.
    Blood. 2005 May 15;105(10):3987-94 PMID: 15665117
  15. A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus.
    J Virol. 1999 Jul;73(7):5722-30 PMID: 10364323
  16. Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway.
    J Virol. 2005 Mar;79(6):3468-78 PMID: 15731241
  17. Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency.
    J Virol. 2003 Nov;77(21):11425-35 PMID: 14557628
  18. Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.
    Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8490-5 PMID: 12832621
  19. p65-NFkappaB synergizes with Notch to activate transcription by triggering cytoplasmic translocation of the nuclear receptor corepressor N-CoR.
    J Cell Sci. 2002 Mar 15;115(Pt 6):1295-303 PMID: 11884528
  20. beta-Adrenoreceptors reactivate Kaposi's sarcoma-associated herpesvirus lytic replication via PKA-dependent control of viral RTA.
    J Virol. 2005 Nov;79(21):13538-47 PMID: 16227274
  21. Effects of NFkappaB activation on KSHV latency and lytic reactivation are complex and context-dependent.
    Virology. 2008 May 25;375(1):94-102 PMID: 18321555
  22. Kaposi's sarcoma-associated herpesvirus K-bZIP is a coregulator of K-Rta: physical association and promoter-dependent transcriptional repression.
    J Virol. 2003 Jan;77(2):1441-51 PMID: 12502859
  23. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease.
    Blood. 1995 Aug 15;86(4):1276-80 PMID: 7632932
  24. Infectious agents and cancer: criteria for a causal relation.
    Semin Cancer Biol. 2004 Dec;14(6):453-71 PMID: 15489139
  25. The mammalian transcriptional repressor RBP (CBF1) regulates interleukin-6 gene expression.
    Mol Cell Biol. 1997 Jan;17(1):1-9 PMID: 8972179
  26. Seroepidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV).
    Semin Cancer Biol. 1999 Jun;9(3):175-85 PMID: 10343069
  27. Crystal structure of the nuclear effector of Notch signaling, CSL, bound to DNA.
    EMBO J. 2004 Sep 1;23(17):3441-51 PMID: 15297877
  28. Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein.
    Virology. 1998 Dec 20;252(2):304-12 PMID: 9878608
  29. Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency.
    Virology. 2006 Aug 1;351(2):393-403 PMID: 16701788
  30. Human herpesvirus 8 acute infection of endothelial cells induces monocyte chemoattractant protein 1-dependent capillary-like structure formation: role of the IKK/NF-kappaB pathway.
    Blood. 2007 Apr 1;109(7):2718-26 PMID: 17138827
  31. Transcriptional regulation of the interleukin-6 gene of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus).
    J Virol. 2002 Aug;76(16):8252-64 PMID: 12134031
  32. Distribution of NF-kappaB-binding sites across human chromosome 22.
    Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12247-52 PMID: 14527995
  33. Initiation of angiogenic Kaposi's sarcoma lesions.
    Cancer Cell. 2003 Jan;3(1):1-3 PMID: 12559168
  34. Genome-wide mapping of RELA(p65) binding identifies E2F1 as a transcriptional activator recruited by NF-kappaB upon TLR4 activation.
    Mol Cell. 2007 Aug 17;27(4):622-35 PMID: 17707233
  35. Activation of CD21 and CD23 gene expression by Kaposi's sarcoma-associated herpesvirus RTA.
    J Virol. 2005 Apr;79(8):4651-63 PMID: 15795251
  36. Functional interactions between an atypical NF-kappaB site from the rat CYP2B1 promoter and the transcriptional repressor RBP-Jkappa/CBF1.
    Nucleic Acids Res. 2000 May 15;28(10):2091-8 PMID: 10773077
  37. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression.
    J Virol. 2004 Apr;78(7):3601-20 PMID: 15016882
  38. T cell leukemia-associated human Notch/translocation-associated Notch homologue has I kappa B-like activity and physically interacts with nuclear factor-kappa B proteins in T cells.
    J Exp Med. 1996 May 1;183(5):2025-32 PMID: 8642313
  39. A comprehensive analysis of recruitment and transactivation potential of K-Rta and K-bZIP during reactivation of Kaposi's sarcoma-associated herpesvirus.
    Virology. 2009 Apr 25;387(1):76-88 PMID: 19269659
  40. Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line.
    J Virol. 2000 Jul;74(13):6207-12 PMID: 10846108
  41. Principal role of TRAP/mediator and SWI/SNF complexes in Kaposi's sarcoma-associated herpesvirus RTA-mediated lytic reactivation.
    Mol Cell Biol. 2003 Mar;23(6):2055-67 PMID: 12612078
  42. Kaposi's sarcoma-associated herpesvirus-encoded protein kinase and its interaction with K-bZIP.
    J Virol. 2007 Feb;81(3):1072-82 PMID: 17108053
  43. Kaposi's Sarcoma-associated herpesvirus open reading frame 50 stimulates the transcriptional activity of STAT3.
    J Biol Chem. 2002 Feb 22;277(8):6438-42 PMID: 11741976
  44. An NF-kappaB gene expression signature contributes to Kaposi's sarcoma virus vGPCR-induced direct and paracrine neoplasia.
    Oncogene. 2008 Mar 20;27(13):1844-52 PMID: 17934524
  45. An essential role of ERK signalling in TPA-induced reactivation of Kaposi's sarcoma-associated herpesvirus.
    J Gen Virol. 2006 Apr;87(Pt 4):795-802 PMID: 16528027
  46. Induction of IL-8 expression by human herpesvirus 8 encoded vFLIP K13 via NF-kappaB activation.
    Oncogene. 2006 May 4;25(19):2717-26 PMID: 16418726
  47. Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator.
    J Virol. 2003 Apr;77(7):4205-20 PMID: 12634378
  48. Kaposi's sarcoma-associated herpesvirus encodes a bZIP protein with homology to BZLF1 of Epstein-Barr virus.
    J Virol. 1999 Mar;73(3):1909-17 PMID: 9971770
  49. Kaposi's sarcoma-associated herpesvirus latent gene vFLIP inhibits viral lytic replication through NF-kappaB-mediated suppression of the AP-1 pathway: a novel mechanism of virus control of latency.
    J Virol. 2008 May;82(9):4235-49 PMID: 18305042
  50. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus.
    Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10866-71 PMID: 9724796
  51. NF-kappaB inhibits gammaherpesvirus lytic replication.
    J Virol. 2003 Aug;77(15):8532-40 PMID: 12857922
  52. Recombination signal sequence binding protein Jkappa is constitutively bound to the NF-kappaB site of the interleukin-6 promoter and acts as a negative regulatory factor.
    Mol Cell Biol. 1997 Jul;17(7):3733-43 PMID: 9199307
  53. Essential role of RBP-Jkappa in activation of the K8 delayed-early promoter of Kaposi's sarcoma-associated herpesvirus by ORF50/RTA.
    Virology. 2007 Mar 1;359(1):19-27 PMID: 17055026
  54. The shortest path from the surface to the nucleus: RBP-J kappa/Su(H) transcription factor.
    Genes Cells. 1996 Jan;1(1):1-9 PMID: 9078362
  55. The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway.
    Genes Dev. 2002 Aug 1;16(15):1977-89 PMID: 12154127
  56. A Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50 deletion mutant is defective for reactivation of latent virus and DNA replication.
    J Virol. 2005 Mar;79(6):3479-87 PMID: 15731242
  57. Direct interactions of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50/Rta protein with the cellular protein octamer-1 and DNA are critical for specifying transactivation of a delayed-early promoter and stimulating viral reactivation.
    J Virol. 2007 Aug;81(16):8451-67 PMID: 17537858
  58. CREB-binding protein/p300 are transcriptional coactivators of p65.
    Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):2927-32 PMID: 9096323
  59. Activation of NF-kappaB by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype.
    J Virol. 2006 Jul;80(14):7179-85 PMID: 16809323
  60. Protein kinase C-alpha is an upstream activator of the IkappaB kinase complex in the TPA signal transduction pathway to NF-kappaB in U2OS cells.
    Cell Signal. 2000 Dec;12(11-12):759-68 PMID: 11152962
  61. Nuclear factor-kappaB binds to the Epstein-Barr Virus LMP1 promoter and upregulates its expression.
    J Virol. 2009 Feb;83(3):1393-401 PMID: 19019967
  62. Shared principles in NF-kappaB signaling.
    Cell. 2008 Feb 8;132(3):344-62 PMID: 18267068
  63. Integrating cell-signalling pathways with NF-kappaB and IKK function.
    Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62 PMID: 17183360
  64. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.
    Science. 1994 Dec 16;266(5192):1865-9 PMID: 7997879
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
1098-5514
Published
2009-05-00
Epub
2009-00-25
Pages
4435-46
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC2668470
Subset
IM
Grants
NCI NIH HHS · P30 CA093373 · United States
NCRR NIH HHS · UL-RR024146 · United States
NCI NIH HHS · CA111185 · United States
NCI NIH HHS · P30 CA93373-04 · United States
NCRR NIH HHS · UL1 RR024146 · United States
NCI NIH HHS · R01 CA111185 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com